Intersect ENT (XENT) Tops Q1 EPS by 10c

Intersect ENT (NASDAQ: XENT) reported Q1 EPS of ($0.23), $0.10 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $13.4 million versus the consensus estimate of $13 million.

For earnings history and earnings-related data on Intersect ENT (XENT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79